Article
A demethylation-driven gene signature predicts prognosis and therapeutic vulnerability in hepatocellular carcinoma.
Scientific reports - 26 Feb 2026
Wang Zhengwei, Shi Lei, Li Yongjian, Liu Sikai, Shi Wanyin
Abstract excerpt
To develop and validate a demethylation-driven gene signature for predicting HCC prognosis, immune microenvironment features, and therapeutic vulnerabilities. We integrated transcriptomic data from TCGA-LIHC (n = 346 tumors) and GEO-GSE112790 (n = 183 tumors) with a curated list of 3,743 demethylation-related genes (DRGs). Tumor-associated DRGs were identified via differential expression analysis and WGCNA. A...
Topics
- Humans
- Liver Neoplasms
- Carcinoma, Hepatocellular
- Prognosis
- Gene Expression Regulation, Neoplastic
- Gene Expression Profiling
- Transcriptome
- Biomarkers, Tumor
- Demethylation
- DNA Methylation
- Tumor Microenvironment
